Spots Global Cancer Trial Database for Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer
Official Title: Phase II Study of Weekly Irinotecan and Carboplatin in Extensive-Stage Small-Cell Lung Cancer
Study ID: NCT00104793
Conditions
Study Description
Brief Summary: RATIONALE: Drugs used in chemotherapy, such as irinotecan and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving irinotecan together with carboplatin may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving irinotecan together with carboplatin works in treating patients with newly diagnosed extensive-stage small cell lung cancer.
Detailed Description: OBJECTIVES: Primary * Determine the response rate in patients with newly diagnosed, previously untreated extensive stage small cell lung cancer treated with irinotecan and carboplatin. Secondary * Determine the progression-free and overall survival of patients treated with this regimen. OUTLINE: This is a multicenter study. Patients receive irinotecan IV and carboplatin IV on days 1 and 8. Treatment repeats every 21 days for 6 courses. PROJECTED ACCRUAL: A total of 55 patients will be accrued for this study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
National Hospital Organization - Dohoku National Hospital, Asahikawa, Hokkaido, Japan
Fujisawa City Hospital, Fujisawa, Kanagawa, Japan
Kurashiki Central Hospital, Kurashiki-shi, Okayama, Japan
Osaka General Medical Center, Osaka-shi, Osaka, Japan
National Hospital Organization - Osaka National Hospital, Sakai, Osaka, Japan
Takatsuki Red Cross Hospital, Takatsuki, Osaka, Japan
Yao Tokusyu-kai General Hospital, Yao, Osaka, Japan
Gunma Cancer Center, Gunma, , Japan
National Hospital Organization - Medical Center of Kure, Hiroshima, , Japan
Osaka Kosei Nenkin Hospital, Osaka, , Japan
Tokyo Medical and Dental University, Tokyo, , Japan
Contact Details
Name: Tadashi Mio, MD
Affiliation: Kyoto University Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
